Literature DB >> 36173482

Evaluation of Exudative Pleural Effusions: A Multicenter, Prospective, Observational Study.

Guntulu Ak1, Selma Metintas2, Ayse Naz Taskın3, Melahat Uzel Sener3, Yasemin Soyler3, Meltem Yilmaz4, Akif Turna5, Pınar Akin Kabalak3, Semra Bilaceroglu6, Deniz Koksal7, Nilgun Yilmaz Demirci8, Ozlem Sogukpinar9, Sibel Boga9, Merve Ercelik10, Gulistan Karadeniz6, Gulru Polat6, Filiz Guldaval6, Ulku Aka Akturk9, Senay Yilmaz11, Nalan Ogan12, Saliha Yilmaz3, Dorina Esendagli13, Benan Caglayan14, Arife Zeybek15, Nagihan Durmus Kocak9, Pinar Mutlu16, Cansel Atinkaya Baytemir17, Ismail Sarbay5, Ulku Yilmaz3, Muzaffer Metintas11.   

Abstract

PURPOSE: The aim of this study is to determine the diagnostic performances of pleural procedures in undiagnosed exudative pleural effusions and to evaluate factors suggestive of benign or malignant pleural effusions in tertiary care centers.
METHODS: This was a multicenter prospective observational study conducted between January 1 and December 31, 2018. A total of 777 patients with undiagnosed exudative pleural effusion after the initial work-up were evaluated. The results of diagnostic procedures and the patients' diagnoses were prospectively recorded. Sensitivity, specificity, and accuracy estimates with 95% confidence intervals were used to examine the performance of pleural procedures to detect malignancy.
RESULTS: The mean age ± SD of the 777 patients was 62.0 ± 16.0 years, and 68.3% of them were male. The most common cause was malignancy (38.3%). Lung cancer was the leading cause of malignant pleural effusions (20.2%). The diagnostic sensitivity and accuracy of cytology were 59.5% and 84.3%, respectively. The diagnostic sensitivity of image-guided pleural biopsy was 86.4%. The addition of image-guided pleural biopsy to cytology increased diagnostic sensitivity to more than 90%. Thoracoscopic biopsy provided the highest diagnostic sensitivity (94.3%). The highest diagnostic sensitivity of cytology was determined in metastatic pleural effusion from breast cancer (86.7%).
CONCLUSION: The diagnostic performance increases considerably when cytology is combined with image-guided pleural biopsy in malignant pleural effusions. However, to avoid unnecessary interventions and complications, the development of criteria to distinguish patients with benign pleural effusions is as important as the identification of patients with malignant pleural effusions.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Benign pleural effusion; Cytological diagnostic sensitivity; Exudative pleural effusion; Image-guided pleural biopsy; Malignant pleural effusion

Year:  2022        PMID: 36173482     DOI: 10.1007/s00408-022-00573-8

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   3.777


  15 in total

1.  What is the significance of non-specific pleuritis? A trick question.

Authors:  Julius Janssen; Fabien Maldonado; Muzaffer Metintas
Journal:  Clin Respir J       Date:  2018-09       Impact factor: 2.570

2.  Investigating unilateral pleural effusions: the role of cytology.

Authors:  David T Arnold; Duneesha De Fonseka; Siobhan Perry; Anna Morley; John E Harvey; Andrew Medford; Mary Brett; Nick A Maskell
Journal:  Eur Respir J       Date:  2018-11-08       Impact factor: 16.671

3.  Idiopathic Pleural Effusions: Characteristics and Discrimination From Cytology-Negative Malignant Pleural Effusions.

Authors:  Ji Eun Park; Young Woo Do; Deok Heon Lee; Sang Yub Lee; Jae Kwang Lim; Sun Ha Choi; Hye Won Seo; Seung Soo Yoo; Shin Yup Lee; Seung Ick Cha; Jae Yong Park; Jaehee Lee; Chang Ho Kim
Journal:  Am J Med Sci       Date:  2020-04-25       Impact factor: 2.378

4.  Pleural effusions: the diagnostic separation of transudates and exudates.

Authors:  R W Light; M I Macgregor; P C Luchsinger; W C Ball
Journal:  Ann Intern Med       Date:  1972-10       Impact factor: 25.391

5.  Outcome of patients diagnosed with fibrinous pleuritis after medical thoracoscopy.

Authors:  Muzaffer Metintas; Guntulu Ak; Omer Cadirci; Huseyin Yildirim; Emine Dundar; Selma Metintas
Journal:  Respir Med       Date:  2012-05-17       Impact factor: 3.415

6.  Medical thoracoscopy vs CT scan-guided Abrams pleural needle biopsy for diagnosis of patients with pleural effusions: a randomized, controlled trial.

Authors:  Muzaffer Metintas; Guntulu Ak; Emine Dundar; Huseyin Yildirim; Ragip Ozkan; Emel Kurt; Sinan Erginel; Fusun Alatas; Selma Metintas
Journal:  Chest       Date:  2010-02-12       Impact factor: 9.410

7.  Prospective Study of the Utility of Computed Tomography Triage of Pleural Biopsy Strategies in Patients With Pleural Diseases.

Authors:  Muzaffer Metintas; Güntülü Ak; Selma Metintas; Huseyin Yildirim; Emine Dündar; Najib Rahman
Journal:  J Bronchology Interv Pulmonol       Date:  2019-07

8.  Etiology of pleural effusions: analysis of more than 3,000 consecutive thoracenteses.

Authors:  José M Porcel; Aureli Esquerda; Manuel Vives; Silvia Bielsa
Journal:  Arch Bronconeumol       Date:  2013-12-20       Impact factor: 4.872

Review 9.  The diagnosis of pleural effusions.

Authors:  José M Porcel; M Azzopardi; C F Koegelenberg; F Maldonado; N M Rahman; Y C G Lee
Journal:  Expert Rev Respir Med       Date:  2015-10-08       Impact factor: 3.772

10.  Outcome of patients with nonspecific pleuritis/fibrosis on thoracoscopic pleural biopsies.

Authors:  Helen E Davies; Jennie E Nicholson; Najib M Rahman; Emily M Wilkinson; Robert J O Davies; Yun Chor Gary Lee
Journal:  Eur J Cardiothorac Surg       Date:  2010-03-12       Impact factor: 4.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.